Comparison of two different volumes of 0.5% bupivacaine for axillary brachial plexus block
Not Applicable
Completed
- Conditions
- Health Condition 1: - Health Condition 2: S529- Unspecified fracture of forearmHealth Condition 3: S529- Unspecified fracture of forearm
- Registration Number
- CTRI/2023/05/052802
- Lead Sponsor
- Department of Anesthesiology & Critical care Pt BD Sharma PGIMS, Rohtak
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
ASA I to III, scheduled to undergo elective below mid-arm surgeries with expected duration less than 3 hours
Exclusion Criteria
Patients with known coagulopathy or on anticoagulant therapy, infection and burn at the injection site, allergy to local anaesthetic, diabetes mellitus, neuropathy, patients receiving opioids for chronic pain therapy, inability to give informed consent, patients with psychiatric illness, pregnant and lactating females
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare efficacy of axillary brachial plexus block with 20ml vs 30ml of drug as judged by success rate, onset time and duration of blockTimepoint: Starting from 5 minutes, every 5 minutes until 30 minutes from end of local anaesthetic injection.
- Secondary Outcome Measures
Name Time Method -procedural pain & patient satisfactionTimepoint: After the block procedure and after the surgery and after 8 hours of block.